Ask AI
ProCE Banner Activity

Addressing Gaps in Heart Failure Care With Practical Tools and SGLT2 Inhibitors 

Clinical Thought

Learn what gaps persist in heart failure care despite having evidence-based guideline-directed medical therapy and the practical tools, including SGLT2 inhibitors, that can be used to improve patient care.

Released: September 26, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company

Disclosure

Primary Author

Javed Butler, MD, MPH, MBA: consultant/advisor/speaker: Abbott, Adaptyx, American Regent, Amgen, AskBio, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardiac Dimension, Cardior, CSL Vifor, CVRx, Cytokinetics, Daxor, Diastol, Edwards, Element Sciences, Faraday, Idorsia, Innolife, Impulse Dynamics, Imbria, Intellia, Inventiva, Levator, Lexicon, Lilly, MannKind, Medtronics, Merck, New Amsterdam, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Pharmain, Prolaio, Pulnovo, Regeneron, Renibus, Reprieve, Roche, Rycarma, Salient, Salamandra, Salubris, SC Pharma, SQ Innovation, Secretome, Sequanna, Transmural, TekkunLev, Tenex, Tricog, Ultromic, Vera, Zoll.